Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes
Inflammatory Bowel Diseases · 2023
DOI: 10.1093/ibd/izac198 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2023. Verfasst von Zeinab Bakhshi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Colitis, Ulcerative, Osteonecrosis. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Mayo Foundation for Medical Education and Research.
Abstract (Originalsprache)
Background
Avascular necrosis (AVN) is a known adverse event associated with corticosteroid (CS) usage. Inflammatory bowel disease (IBD) is often treated with a CS for induction of remission. We sought to describe clinical features and outcomes of IBD patients with AVN.
Methods
In this retrospective, single-center, case-control study, patients with IBD who had a diagnosis of osteonecrosis, aseptic necrosis, or AVN from 1976 to 2009 were included, and each was matched with up to 2 controls (IBD but no AVN) on age, sex, IBD subtype, geographic area of residence, and date of IBD diagnosis. We abstracted risk factor data from the medical records. Conditional logistic regression was performed accounting for minor differences in age and date of first IBD visit to assess the relationship between putative risk factors and AVN, expressed as odds ratio and 95% confidence interval.
Results
Eighty-five patients were diagnosed with IBD-AVN and were matched with 163 controls. The mean age at AVN diagnosis was 47.5 years. AVN was diagnosed a median of 12.2 years after IBD diagnosis, and the control group was followed for a median of 15 years after IBD diagnosis to ensure that they did not have AVN. Ten percent of patients with AVN did not have any CS exposure. History of arthropathy or estrogen use in Crohn’s disease and use of CS, osteoporosis, and history of arthropathy in ulcerative colitis were significantly associated with AVN.
Conclusions
Most patients with IBD-AVN had multifocal involvement. Most had received CS, but many patients had other risk factors including arthropathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
- Division of General Internal Medicine, Mayo Clinic, Rochester, MN, USA.
- Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.
- Department of Family Medicine, Mayo Clinic, Rochester, MN, USA.
- St. Alexius Medical Center, Bismarck, ND, USA.
ORCID-Profile: Edward V Loftus
Förderung
- Mayo Foundation for Medical Education and Research
Zitieren
APA
Bakhshi, Z., Yadav, S., Harmsen, W. S., Edakkanambeth Varayil, J., Karls, K. A., Tremaine, W. J., & Loftus, E. V. (2023). Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izac198
Vancouver
Bakhshi Z, Yadav S, Harmsen WS, Edakkanambeth Varayil J, Karls KA, Tremaine WJ, et al. Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes. Inflammatory Bowel Diseases. 2023. doi:10.1093/ibd/izac198
BibTeX
@article{Bakhshi2023,
author = {Bakhshi, Zeinab and Yadav, Siddhant and Harmsen, W Scott and Edakkanambeth Varayil, Jithinraj and Karls, Kevin A and Tremaine, William J and Loftus, Edward V},
title = {Osteonecrosis in Inflammatory Bowel Disease: Clinical Features, Risk Factor Analysis, and Outcomes},
journal = {Inflammatory Bowel Diseases},
year = {2023},
doi = {10.1093/ibd/izac198}
}
EUVIMED